- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04676698
Three Good Things 2020: a Brief Text-based Wellness Intervention
This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff.
The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention.
At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Michigan
-
Ann Arbor, Michigan, États-Unis, 48109
- University of Michigan
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Faculty, resident, or staff in the Michigan Medicine (MM) Department of Family Medicine
Exclusion Criteria:
- Not a member of Family Medicine at MM
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: Three Good Things
Three times weekly for three weeks, participants will receive a text-based survey asking them to type or dictate "three good things."
|
The treatment phase will last 3 weeks.
However, participants will complete surveys at baseline and up to 6 months.
At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed.
These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.
|
Comparateur actif: Waitlist Control Arm then Three Good Things
Participants will have surveys in the waiting period for 3 months and then be crossed over to the treatment arm Three Good Things.
|
Surveys will be completed for 3 months prior to treatment and then after treatment.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in the Positive and Negative Affect Schedule (PANAS-SF) between the intervention and control group
Délai: Pre-Treatment (baseline), up to 6 months
|
This is a 10 item survey to measure positive and negative affect.
Responses include; very slightly or not at all, a little, quite a bit, and extremely.
Higher scores of Positive Affect (PA) subscale represent higher positive affect higher scores of Negative affect (NA) subscale represent higher negative affect.
|
Pre-Treatment (baseline), up to 6 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Change in self-reported physical health
Délai: Pre-Treatment (baseline), up to 6 months
|
This is a 1 question item to assess participants physical health ( 1=Excellent 2=good 3=fair 4=poor).
|
Pre-Treatment (baseline), up to 6 months
|
Change in self-reported mental health
Délai: Pre-Treatment (baseline), up to 6 months
|
This is a 1 question item to assess participants mental health ( 1=Excellent 2=good 3=fair 4=poor).
|
Pre-Treatment (baseline), up to 6 months
|
Change in Gratitude using the Gratitude Adjective Checklist (GAC)
Délai: Pre-Treatment (baseline), up to 6 months
|
The GAC is a 3-item self-report measure of state gratitude in which participants select, (1) A little (2) Moderately, Quite a bit (4), and Extremely (5).The total score on GAC ranges from 3 to 15, with higher score indicating greater state gratitude.
|
Pre-Treatment (baseline), up to 6 months
|
Change in depression using the Patient Health Questionnaire 9-item (PHQ-9) score
Délai: Pre-Treatment (baseline) to 6 months
|
PHQ-9 scores reflect depression severity.
Participants will select responses that include 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day.
Ranges in scores are from 0-27 (Scores: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe).
|
Pre-Treatment (baseline) to 6 months
|
Change in Satisfaction with Life Questionnaire
Délai: Pre-Treatment (baseline), up to 6 months
|
This is a 5 question questionnaire in which participants select from 7 responses that are given a 1-7 scale from strongly disagree to strongly agree.
Scoring ranges from 5-35 where 20 = neutral (the higher the score the more satisfaction).
|
Pre-Treatment (baseline), up to 6 months
|
Change in the Hope Scale
Délai: Pre-Treatment (baseline), up to 6 months
|
This is a 12 item questionnaire in which participants select from answers that include 1=definitely false 2=mostly false 3=mostly true 4=definitely true. Scores range from 12-48 with higher scores indicating greater hope. |
Pre-Treatment (baseline), up to 6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Katherine Gold, MD, University of Michigan
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HUM00188399
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Stress lié au travail
-
National Institute of Allergy and Infectious Diseases...RésiliéImmunodéficience | Syndrome de JOB | Syndrome d'infection récurrente hyper-IgEÉtats-Unis
-
Shanghai Children's Medical CenterInconnue
-
National Institute of Allergy and Infectious Diseases...ComplétéSyndrome de Job | Syndrome hyper-IgEÉtats-Unis
-
National Institute of Allergy and Infectious Diseases...ComplétéMaladie granulomateuse, chronique | Infection | Syndrome de JobÉtats-Unis
-
National Institute of Allergy and Infectious Diseases...Albert Einstein College of MedicineRecrutementInfections | Maladies du système immunitaire | Pneumonie | Syndrome de l'emploi | Facteur de transcription STAT3États-Unis
-
National Institute of Allergy and Infectious Diseases...ComplétéMaladie granulomateuse chronique | Trouble leucocytaire | Syndrome de Job | Syndrome de Chediak HigashiÉtats-Unis
-
National Institutes of Health Clinical Center (CC)ComplétéMaladie granulomateuse chronique | Granulomatose de Wegener | Syndrome de Job | Carcinome bronchique | Infection à mycobactérieÉtats-Unis
Essais cliniques sur Three Good Things
-
Marshall UniversityUniversity of Toronto; University of Southern DenmarkRecrutementArthrose, GenouÉtats-Unis
-
Mead Johnson NutritionComplétéNourrissons nés à terme et en bonne santé uniquement nourris au lait materniséÉtats-Unis
-
Hartford HospitalUniversity of Maryland; University of ConnecticutComplétéRéaction inflammatoire | Prolapsus des organes pelviens | DysbioseÉtats-Unis
-
Philipps University Marburg Medical CenterProf. Dr. Andreas Bechdolf (Chair of hospital), Vivantes Hospital Am Urban... et autres collaborateursComplétéDétresse émotionelle | Délires | Amour propre | Psychose précoceAllemagne